Evidence map›Paper›PMID 22395730›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2012

Cocaine self-administration produces pharmacodynamic tolerance: differential effects on the potency of dopamine transporter blockers, releasers, and methylphenidate.

Mark J Ferris, Erin S Calipari, Yolanda Mateo, James R Melchior, David C S Roberts, Sara R Jones

Open access · bronzeAbstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 83 citations in OpenAlex.

  1. Hypocretin receptor 1 blockade early in abstinence prevents incubation of cocaine seeking and normalizes dopamine transmission.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Article
  2. Synaptogyrin-3 plays a critical role in addiction-related dopamine dysfunction and behavioral maladaptations.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Disrupted Decision-Making: EcoHIV Inoculation in Cocaine Dependent Rats.International journal of molecular sciences · 2022
    Article
  15. Review
  16. Article
  17. Enhanced heroin self-administration and distinct dopamine adaptations in female rats.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2021
    Article
  18. Chemogenetic Manipulation of Dopamine Neurons Dictates Cocaine Potency at Distal Dopamine Transporters.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2020
    Article
  19. Review
  20. Operant Costs Modulate Dopamine Release to Self-Administered Cocaine.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Mark J FerrisDepartment of Physiology and Pharmacology, Wake Forest School of Medicine, Winston-Salem, NC 27157, USA. mferris@wakehealth.edu
Erin S Calipari
Yolanda Mateo
James R Melchior
David C S Roberts
Sara R Jones
Wake Forest University · USNational Institutes of Health · US

Funding

TROPANE EVALUATION AND GENERAL SCIENTIFIC SERVICES COREP50DA006634 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI FERRIS, MARK J · 1991 to 2019
$30.8M
A Novel Animal Model of Cocaine AddictionR01DA014030 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI JONES, SARA RAULERSON · 2001 to 2015
$3.2M
NEUROSCIENCE OF DRUG ABUSE TRAINING PROGRAMT32DA007246 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI CHILDERS, STEVEN R · 1991 to 2011
$2.2M
Dopamine Transporter Changes Following Cocaine Self-AdministrationR01DA021325 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI JONES, SARA RAULERSON · 2007 to 2011
$1.4M
Methylphenidate, Serotonin and Dopamine InteractionsR01DA030161 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI JONES, SARA RAULERSON · 2010 to 2014
$1.4M
nAChR Sensitivity and Individual Differences in Drug Abuse VulnerabilityK99DA031791 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI FERRIS, MARK J · 2012 to 2013
$188k
The effect of methylphenidate use and abuse on dopamine system kineticsF31DA031533 · NIDA · WAKE FOREST UNIVERSITY HEALTH SCIENCES · PI CALIPARI, ERIN · 2012 to 2013
$63k
NIDA NIH HHS F31 DA031533NIDA NIH HHS K99 DA031791NIDA NIH HHS P50 DA006634NIDA NIH HHS P50DA006634NIDA NIH HHS R01 DA014030NIDA NIH HHS R01DA014030NIDA NIH HHS R01 DA021325NIDA NIH HHS R01DA021325NIDA NIH HHS R01 DA030161NIDA NIH HHS R01DA030161NIDA NIH HHS T31DA007246NIDA NIH HHS T32 DA007246NIDA NIH HHS T32DA007246PHS HHS BIDA031533
6 · The paper itself

Abstract

The dopamine transporter (DAT) is the primary site of action for psychostimulant drugs such as cocaine, methylphenidate, and amphetamine. Our previous work demonstrated a reduced ability of cocaine to inhibit the DAT following high-dose cocaine self-administration (SA), corresponding to a reduced ability of cocaine to increase extracellular dopamine. However, this effect had only been demonstrated for cocaine. Thus, the current investigations sought to understand the extent to which cocaine SA (1.5 mg/kg/inf × 40 inf/day × 5 days) altered the ability of different dopamine uptake blockers and releasers to inhibit dopamine uptake, measured using fast-scan cyclic voltammetry in rat brain slices. We demonstrated that, similar to cocaine, the DAT blockers nomifensine and bupropion were less effective at inhibiting dopamine uptake following cocaine SA. The potencies of amphetamine-like dopamine releasers such as 3,4-methylenedioxymethamphetamine, methamphetamine, amphetamine, and phentermine, as well as a non-amphetamine releaser, 4-benzylpiperidine, were all unaffected. Finally, methylphenidate, which blocks dopamine uptake like cocaine while being structurally similar to amphetamine, shared characteristics of both, resembling an uptake blocker at low concentrations and a releaser at high concentrations. Combined, these experiments demonstrate that after high-dose cocaine SA, there is cross-tolerance of the DAT to other uptake blockers, but not releasers. The reduced ability of psychostimulants to inhibit dopamine uptake following cocaine SA appears to be contingent upon their functional interaction with the DAT as a pure blocker or releaser rather than their structural similarity to cocaine. Further, methylphenidate's interaction with the DAT is unique and concentration-dependent.

Indexed as

AnimalsBupropionCocaineDopamineDopamine Plasma Membrane Transport ProteinsDopamine Uptake InhibitorsDose-Response Relationship, DrugDrug ToleranceMaleMethylphenidateNomifensineRatsRats, Sprague-DawleySelf AdministrationBupropionCocaineDopamineDopamine Plasma Membrane Transport ProteinsDopamine Uptake InhibitorsMethylphenidateNomifensine

Identifiers

PMID22395730
PMCPMC3358740
OpenAlexW1989459745

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.